{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:46:51Z","timestamp":1791229611646,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02473-6","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T11:03:51Z","timestamp":1668596631000},"page":"989-997","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy of a triamcinolone acetonide-loaded dissolving microneedle patch for the treatment of hypertrophic scars and keloids: a randomized, double-blinded, placebo-controlled split-scar study"],"prefix":"10.1007","volume":"315","author":[{"given":"Wareeporn","family":"Disphanurat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakarin","family":"Sivapornpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjaporn","family":"Srisantithum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeerapond","family":"Leelawattanachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"2473_CR1","doi-asserted-by":"publisher","first-page":"79e","DOI":"10.1097\/prs.0000000000008667","volume":"149","author":"R Ogawa","year":"2022","unstructured":"Ogawa R (2022) The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg 149:79e\u201394e. https:\/\/doi.org\/10.1097\/prs.0000000000008667","journal-title":"Plast Reconstr Surg"},{"key":"2473_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1742-481X.2012.01118.x","volume":"11","author":"C Huang","year":"2014","unstructured":"Huang C, Akaishi S, Hyakusoku H, Ogawa R (2014) Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings. Int Wound J 11:517\u2013522. https:\/\/doi.org\/10.1111\/j.1742-481X.2012.01118.x","journal-title":"Int Wound J"},{"key":"2473_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/DSS.0000000000000819","volume":"43","author":"B Berman","year":"2017","unstructured":"Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43:S3\u2013S18. https:\/\/doi.org\/10.1097\/DSS.0000000000000819","journal-title":"Dermatol Surg"},{"key":"2473_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/sj.jid.5700274","volume":"126","author":"WS Wu","year":"2006","unstructured":"Wu WS, Wang FS, Yang KD, Huang CC, Kuo YR (2006) Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol 126:1264\u20131271. https:\/\/doi.org\/10.1038\/sj.jid.5700274","journal-title":"J Invest Dermatol"},{"key":"2473_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/ccid.s133672","volume":"11","author":"M Morelli Coppola","year":"2018","unstructured":"Morelli Coppola M, Salzillo R, Segreto F, Persichetti P (2018) Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives. Clin Cosmet Investig Dermatol 11:387\u2013396. https:\/\/doi.org\/10.2147\/ccid.s133672","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2473_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/02844310500430003","volume":"40","author":"G Muneuchi","year":"2006","unstructured":"Muneuchi G, Suzuki S, Onodera M, Ito O, Hata Y, Igawa HH (2006) Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg 40:111\u2013116. https:\/\/doi.org\/10.1080\/02844310500430003","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"2473_CR7","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1021\/js980042+","volume":"87","author":"S Henry","year":"1998","unstructured":"Henry S, McAllister DV, Allen MG, Prausnitz MR (1998) Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 87:922\u2013925. https:\/\/doi.org\/10.1021\/js980042+","journal-title":"J Pharm Sci"},{"key":"2473_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/10717541003667798","volume":"17","author":"RF Donnelly","year":"2010","unstructured":"Donnelly RF, Raj Singh TR, Woolfson AD (2010) Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv 17:187\u2013207. https:\/\/doi.org\/10.3109\/10717541003667798","journal-title":"Drug Deliv"},{"key":"2473_CR9","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.biopha.2017.07.019","volume":"93","author":"K Ita","year":"2017","unstructured":"Ita K (2017) Dissolving microneedles for transdermal drug delivery: advances and challenges. Biomed Pharmacother 93:1116\u20131127. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.019","journal-title":"Biomed Pharmacother"},{"key":"2473_CR10","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1016\/j.vaccine.2018.06.025","volume":"36","author":"Q Yan","year":"2018","unstructured":"Yan Q, Cheng Z, Liu H et al (2018) Enhancement of Ag85B DNA vaccine immunogenicity against tuberculosis by dissolving microneedles in mice. Vaccine 36:4471\u20134476. https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.025","journal-title":"Vaccine"},{"key":"2473_CR11","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/jocd.12807","volume":"18","author":"G Kang","year":"2019","unstructured":"Kang G, Kim S, Yang H et al (2019) Combinatorial application of dissolving microneedle patch and cream for improvement of skin wrinkles, dermal density, elasticity, and hydration. J Cosmet Dermatol 18:1083\u20131091. https:\/\/doi.org\/10.1111\/jocd.12807","journal-title":"J Cosmet Dermatol"},{"key":"2473_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40001-017-0269-6","volume":"22","author":"DC Yeo","year":"2017","unstructured":"Yeo DC, Balmayor ER, Schantz JT, Xu C (2017) Microneedle physical contact as a therapeutic for abnormal scars. Eur J Med Res 22:28. https:\/\/doi.org\/10.1186\/s40001-017-0269-6","journal-title":"Eur J Med Res"},{"key":"2473_CR13","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1097\/01.prs.0000122207.28773.56","volume":"113","author":"LJ Draaijers","year":"2004","unstructured":"Draaijers LJ, Tempelman FR, Botman YA et al (2004) The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg 113:1960\u20131965. https:\/\/doi.org\/10.1097\/01.prs.0000122207.28773.56","journal-title":"Plast Reconstr Surg"},{"key":"2473_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.addr.2003.10.023","volume":"56","author":"MR Prausnitz","year":"2004","unstructured":"Prausnitz MR (2004) Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581\u2013587. https:\/\/doi.org\/10.1016\/j.addr.2003.10.023","journal-title":"Adv Drug Deliv Rev"},{"key":"2473_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jconrel.2017.05.029","volume":"260","author":"S Bhatnagar","year":"2017","unstructured":"Bhatnagar S, Dave K, Venuganti VVK (2017) Microneedles in the clinic. J Control Release 260:164\u2013182. https:\/\/doi.org\/10.1016\/j.jconrel.2017.05.029","journal-title":"J Control Release"},{"key":"2473_CR16","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","volume":"64","author":"YC Kim","year":"2012","unstructured":"Kim YC, Park JH, Prausnitz MR (2012) Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64:1547\u20131568. https:\/\/doi.org\/10.1016\/j.addr.2012.04.005","journal-title":"Adv Drug Deliv Rev"},{"key":"2473_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2147\/ccid.s267192","volume":"13","author":"MLW Juhasz","year":"2020","unstructured":"Juhasz MLW, Cohen JL (2020) Microneedling for the treatment of scars: an update for clinicians. Clin Cosmet Investig Dermatol 13:997\u20131003. https:\/\/doi.org\/10.2147\/ccid.s267192","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2473_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/exd.12723","volume":"24","author":"MT McCrudden","year":"2015","unstructured":"McCrudden MT, McAlister E, Courtenay AJ, Gonz\u00e1lez-V\u00e1zquez P, Singh TR, Donnelly RF (2015) Microneedle applications in improving skin appearance. Exp Dermatol 24:561\u2013566. https:\/\/doi.org\/10.1111\/exd.12723","journal-title":"Exp Dermatol"},{"key":"2473_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/pharmaceutics13081132","volume":"13","author":"PR Yadav","year":"2021","unstructured":"Yadav PR, Munni MN, Campbell L et al (2021) Translation of polymeric microneedles for treatment of human diseases: recent trends, progress, and challenges. Pharmaceutics 13:1132. https:\/\/doi.org\/10.3390\/pharmaceutics13081132","journal-title":"Pharmaceutics"},{"key":"2473_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijpharm.2011.10.032","volume":"427","author":"D Jiang","year":"2012","unstructured":"Jiang D, Salem AK (2012) Optimized dextran-polyethylenimine conjugates are efficient non-viral vectors with reduced cytotoxicity when used in serum containing environments. Int J Pharm 427:71\u201379. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.10.032","journal-title":"Int J Pharm"},{"key":"2473_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ijbiomac.2019.11.151","volume":"145","author":"F Chen","year":"2020","unstructured":"Chen F, Huang G, Huang H (2020) Preparation and application of dextran and its derivatives as carriers. Int J Biol Macromol 145:827\u2013834. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.11.151","journal-title":"Int J Biol Macromol"},{"key":"2473_CR22","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.2217\/nnm-2018-0331","volume":"13","author":"G Huang","year":"2018","unstructured":"Huang G, Huang H (2018) Application of dextran as nanoscale drug carriers. Nanomedicine (Lond) 13:3149\u20133158. https:\/\/doi.org\/10.2217\/nnm-2018-0331","journal-title":"Nanomedicine (Lond)"},{"key":"2473_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijpharm.2010.02.007","volume":"391","author":"G Yan","year":"2010","unstructured":"Yan G, Warner KS, Zhang J, Sharma S, Gale BK (2010) Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Int J Pharm 391:7\u201312. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.02.007","journal-title":"Int J Pharm"},{"key":"2473_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2119\/molmed.2009.00153","volume":"17","author":"GG Gauglitz","year":"2011","unstructured":"Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17:113\u2013125. https:\/\/doi.org\/10.2119\/molmed.2009.00153","journal-title":"Mol Med"},{"key":"2473_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/bjd.14844","volume":"176","author":"GC Limandjaja","year":"2017","unstructured":"Limandjaja GC, van den Broek LJ, Waaijman T et al (2017) Increased epidermal thickness and abnormal epidermal differentiation in keloid scars. Br J Dermatol 176:116\u2013126. https:\/\/doi.org\/10.1111\/bjd.14844","journal-title":"Br J Dermatol"},{"key":"2473_CR26","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1177\/24726303211024568","volume":"26","author":"Y Yang","year":"2021","unstructured":"Yang Y, Xia L, Ning X, Hu T, Xu C, Liu W (2021) Enhanced drug permeation into human keloid tissues by sonophoresis-assisted microneedling. SLAS Technol 26:660\u2013666. https:\/\/doi.org\/10.1177\/24726303211024568","journal-title":"SLAS Technol"},{"key":"2473_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/pde.12746","volume":"33","author":"S Acosta","year":"2016","unstructured":"Acosta S, Ureta E, Ya\u00f1ez R, Oliva N, Searle S, Guerra C (2016) Effectiveness of intralesional triamcinolone in the treatment of keloids in children. Pediatr Dermatol 33:75\u201379. https:\/\/doi.org\/10.1111\/pde.12746","journal-title":"Pediatr Dermatol"},{"key":"2473_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/dsu.0000000000000050","volume":"40","author":"MH Gold","year":"2014","unstructured":"Gold MH, McGuire M, Mustoe TA et al (2014) Updated international clinical recommendations on scar management: part 2\u2014algorithms for scar prevention and treatment. Dermatol Surg 40:825\u2013831. https:\/\/doi.org\/10.1111\/dsu.0000000000000050","journal-title":"Dermatol Surg"},{"key":"2473_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00403-013-1328-7","volume":"305","author":"S Ud-Din","year":"2013","unstructured":"Ud-Din S, Bowring A, Derbyshire B, Morris J, Bayat A (2013) Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease. Arch Dermatol Res 305:423\u2013432. https:\/\/doi.org\/10.1007\/s00403-013-1328-7","journal-title":"Arch Dermatol Res"},{"key":"2473_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.burns.2021.02.013","volume":"47","author":"Z Zhuang","year":"2021","unstructured":"Zhuang Z, Li Y, Wei X (2021) The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: a systematic review and meta-analysis. Burns 47:987\u2013998. https:\/\/doi.org\/10.1016\/j.burns.2021.02.013","journal-title":"Burns"},{"key":"2473_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jconrel.2019.05.038","volume":"306","author":"S Lin","year":"2019","unstructured":"Lin S, Quan G, Hou A et al (2019) Strategy for hypertrophic scar therapy: Improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array. J Control Release 306:69\u201382. https:\/\/doi.org\/10.1016\/j.jconrel.2019.05.038","journal-title":"J Control Release"},{"key":"2473_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s13555-019-00316-3","volume":"9","author":"CWX Tan","year":"2019","unstructured":"Tan CWX, Tan WD, Srivastava R, Yow AP, Wong DWK, Tey HL (2019) Dissolving triamcinolone-embedded microneedles for the treatment of keloids: a single-blinded intra-individual controlled clinical trial. Dermatol Ther (Heidelb) 9:601\u2013611. https:\/\/doi.org\/10.1007\/s13555-019-00316-3","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02473-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T07:06:16Z","timestamp":1681110376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02473-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2473"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02473-6","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"9 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial or non-financial competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This prospective randomized, double-blind, split-scar controlled trial was approved by the Institutional Review Board of Thammasat University, Thailand (MTU-EC-IM-4-037\/643). The study was conducted in accordance with good clinical practice guidelines and the 1975 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants prior to treatment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}